VanEck Associates’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
286,020
+60,430
| +27% | +$3.11M | 0.02% | 388 |
|
|
2025
Q1 | $13.2M | Buy |
225,590
+54,033
| +31% | +$3.17M | 0.02% | 400 |
|
|
2024
Q4 | $12.4M | Buy |
171,557
+49,574
| +41% | +$3.57M | 0.02% | 410 |
|
|
2024
Q3 | $8.46M | Sell |
121,983
-20,226
| -14% | -$1.4M | 0.01% | 497 |
|
|
2024
Q2 | $10.2M | Buy |
142,209
+3,373
| +2% | +$242K | 0.01% | 411 |
|
|
2024
Q1 | $9.77M | Sell |
138,836
-4,065
| -3% | -$286K | 0.01% | 408 |
|
|
2023
Q4 | $11M | Sell |
142,901
-22,664
| -14% | -$1.75M | 0.02% | 347 |
|
|
2023
Q3 | $11.3M | Buy |
165,565
+7,096
| +4% | +$483K | 0.02% | 322 |
|
|
2023
Q2 | $12.9M | Sell |
158,469
-5,787
| -4% | -$472K | 0.03% | 307 |
|
|
2023
Q1 | $12.2M | Sell |
164,256
-24,551
| -13% | -$1.82M | 0.03% | 315 |
|
|
2022
Q4 | $15.6M | Buy |
188,807
+39,531
| +26% | +$3.28M | 0.04% | 269 |
|
|
2022
Q3 | $10.6M | Sell |
149,276
-62,852
| -30% | -$4.46M | 0.03% | 299 |
|
|
2022
Q2 | $18.4M | Buy |
212,128
+11,564
| +6% | +$1M | 0.05% | 251 |
|
|
2022
Q1 | $21.7M | Buy |
200,564
+9,832
| +5% | +$1.06M | 0.04% | 240 |
|
|
2021
Q4 | $24.7M | Sell |
190,732
-4,864
| -2% | -$629K | 0.06% | 228 |
|
|
2021
Q3 | $23.7M | Buy |
+195,596
| New | +$23.7M | 0.06% | 233 |
|
|
2021
Q2 | – | Sell |
-840
| Closed | -$80K | – | 1312 |
|
|
2021
Q1 | $80K | Buy |
+840
| New | +$80K | ﹤0.01% | 1032 |
|